Loading company…
Sequence Bio uses systems biology and data computation to build customized discovery cohorts for drug developers.
Its resources include founder population multi-omics, real-world patient data and characterized phenotypes, and it works mainly with pharmaceutical and biotech companies. Founded in 2013 and based in St. John's, Canada, the company is at the Seed stage. It raised CAD 3.9 million in a Seed round led by Data Collective on August 3, 2016, and Lynn Healey and Sam Rasty are its current CEOs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in